You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Blast Crisis

Showing 26 - 50 of 1,113
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Accelerated Phase Chronic Myelogenous Leukemia (CML), Blast Phase Chronic Myelogenous Leukemia (CML), Chronic Phase Phase

Terminated
  • Accelerated Phase Chronic Myelogenous Leukemia (CML)
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2020

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia Trial in Houston (Clofarabine 40mg/m^2, Idarubicin

Completed
Has Results
  • Acute Myeloid Leukemia
  • +2 more
  • Clofarabine 40mg/m^2
  • +5 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 3, 2020

Leukemia Trial in Houston (Dasatinib, Decitabine)

Terminated
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 29, 2020

Chronic Phase Chronic Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blastic Phase Chronic Myeloid Leukemia Trial

Completed
  • Chronic Phase Chronic Myeloid Leukemia
  • +4 more
  • Toronto, Ontario, Canada
    Princess Margaret Hospital / University Health Network
Oct 29, 2020

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia With

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +5 more
  • Blinatumomab
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2022

Chronic Myelogenous Leukemia Trial in Canada, United States (decitabine (5-aza-2'deoxycytidine))

Completed
  • Chronic Myelogenous Leukemia
  • decitabine (5-aza-2'deoxycytidine)
  • Duarte, California
  • +7 more
Jan 13, 2020

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
Has Results
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +23 more
  • Denver, Colorado
  • +2 more
Jun 17, 2021

Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute

Completed
Has Results
  • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +5 more
  • Therapeutic Allogeneic Lymphocytes
  • Seattle, Washington
  • +3 more
Jan 15, 2020

CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey

Completed
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
    • Limerick, Dooradoyle, Ireland
    • +32 more
    Aug 13, 2021

    Philadelphia Positive Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Worldwide (STI571

    Completed
    Has Results
    • Philadelphia Positive Chronic Myeloid Leukemia
    • +2 more
    • STI571 400 mg
    • STI571 600 mg
    • Boston, Massachusetts
    • +11 more
    Jul 1, 2021

    Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial

    Completed
    Has Results
    • Chronic Myelogenous Leukemia
    • +3 more
    • Duarte, California
    • +100 more
    Jun 8, 2021

    Outcomes in Chronic Myeloid Leukaemia

    Completed
    • Chronic Myeloid Leukaemia
      • York, United Kingdom
        Haematological Malignancy Research Network
      Jun 7, 2023

      Describe Real World Use of Bosutinib inSingle Centre in Scotland

      Completed
      • Myeloid Leukemia
      • Glasgow, United Kingdom
        eatson West of Scotland Cancer Centre
      May 3, 2022

      Chronic Myelogenous Leukemia - Chronic Phase Trial (asciminib)

      Recruiting
      • Chronic Myelogenous Leukemia - Chronic Phase
      • Birmingham, Alabama
      • +25 more
      Jan 10, 2023

      According to Molecular Identification at Diagnosis

      Not yet recruiting
      • Chronic Myeloid Leukemia
      • Next Generation Sequencing (DNA and RNA)
      • (no location specified)
      Oct 28, 2022

      Chronic Myeloid Leukemia, Chronic Phase, Nilotinib Trial in Shenzhen (Nilotinib)

      Recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
      • Nilotinib
      • Shenzhen, Guangdong, China
        Shenzhen Second People's Hospital
      Mar 15, 2022

      Leukemia, Myelogenous, Chronic, BCR-ABL Positive Trial in France (Nilotinib)

      Completed
      • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
      • Angers, France
      • +9 more
      Aug 17, 2022

      Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

      Completed
      Has Results
      • Chronic Myeloid Leukemia
      • Omacetaxine mepesuccinate
      • Los Angeles, California
      • +31 more
      Nov 11, 2021

      Blood and Bone Marrow Samples in Chronic Myelogenous Leukemia

      Active, not recruiting
      • Leukemia
      • DNA analysis
      • +3 more
      • San Diego, California
      • +160 more
      Aug 2, 2022

      Effect of Pharmacogenetics on Imatinib Plasma Level and Response

      Active, not recruiting
      • Chronic Myeloid Leukemia
      • PCR
      • HPLC-UV
      • Assiut, Egypt
        South Egypt Cancer Institute
      Aug 6, 2022

      Chronic Phase Chronic Myeloid Leukemia Trial in Worldwide (Dasatinib)

      Completed
      Has Results
      • Chronic Phase Chronic Myeloid Leukemia
      • Duarte, California
      • +27 more
      Dec 7, 2021

      Hematologic Malignancy Trial in United States (BBI608, Dexamethasone, Bortezomib)

      Completed
      • Hematologic Malignancy
      • Denver, Colorado
      • +7 more
      Apr 4, 2022

      Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Trial in Worldwide (Imatinib, Nilotinib, Bosutinib)

      Recruiting
      • Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
      • Longmont, Colorado
      • +128 more
      Aug 1, 2022

      Chronic Myeloid Leukemia Trial in Saint-Étienne (Pharmaceutical intervention)

      Recruiting
      • Chronic Myeloid Leukemia
      • Pharmaceutical intervention
      • Saint-Étienne, France
        CHU de Saint-Etienne
      Feb 24, 2022